Drinking enough water is very important during long periods of physical activity or recreational pursuits. But there are rare instances when too much fluid intake can be harmful, and even lead to death.
Sep 28, 2012
1
0
(HealthDay)—A newly developed spatial frequency domain imaging (SFDI) device can be used to quantify biochemical compositional changes in port wine stain (PWS) lesions after laser therapy, according to a study published ...
Sep 10, 2012
0
0
A new study has found evidence that marathon running could trigger pulmonary oedema, where fluid builds up in the lungs.
Sep 4, 2012
0
0
People whose blood sugar is on the high end of the normal range may be at greater risk of brain shrinkage that occurs with aging and diseases such as dementia, according to new research published in the September 4, 2012, ...
Sep 3, 2012
1
0
A sedentary lifestyle is a common cause of obesity, and excessive body weight and fat in turn are considered catalysts for diabetes, high blood pressure, joint damage and other serious health problems. But what if lack of ...
Aug 13, 2012
0
0
Major depression or chronic stress can cause the loss of brain volume, a condition that contributes to both emotional and cognitive impairment. Now a team of researchers led by Yale scientists has discovered one reason why ...
Aug 12, 2012
3
1
Researchers from Boston University School of Medicine (BUSM) and Veterans Affairs (VA) Boston Healthcare System have demonstrated that the effects on white matter brain volume from long-term alcohol abuse are different for ...
Aug 9, 2012
0
0
Events that take place early in life almost certainly have consequences for later cognitive development. Establishing the connections is difficult, however, because human infants cannot be used as laboratory subjects.
Jul 25, 2012
0
0
(HealthDay) -- Evidence is mounting that exercise provides some protection from memory loss and Alzheimer's disease, with three new studies showing that a variety of physical activities are associated with healthier brains ...
Jul 16, 2012
0
0
The medication fingolimod reduced inflammatory lesion activity and reduced brain volume loss in patients with multiple sclerosis who participated in a two-year placebo-controlled clinical trial and were assessed by magnetic ...
Jul 2, 2012
0
0
